We offer modern, physician-guided weight-management treatments using GLP-1 medications such as Semaglutide & Tirzepatide (Ozempic®, Zepbound®), and emerging therapies like retatrutide. These medications work by regulating appetite, improving insulin sensitivity, and supporting metabolic health, making them effective for both weight loss and diabetes management when clinically appropriate.
Same active ingredient as Ozempic, Wegovy; compounded by FDA-Registered 503A/B pharmacies.
In major Obesity trials the average weight loss was: 15%
Semaglutide hits 1 receptor: GLP‑1, this helps with appetite suppression, insulin boost. Typically has most side effects out of the three GLP-1 options, most common side effect is nausea (however we can send nausea medication as needed to your local pharmacy, just ask).
Same active ingredient as Zepbound, Mounjaro; compounded by FDA-Registered 503A/B pharmacies.
In major Obesity trials the average weight loss was: 21%
Tirzepatide hits 2 receptors: GLP‑1, GIP: this enhances weight loss and glucose control!
Compounded by FDA-Registered 503A/B pharmacies.
In major Obesity trials the average weight loss was: 25%
Retatrutide hits 3 receptors: GLP‑1, GIP, Glucagon therefore it has the strongest metabolic and fat‑burning effects.
